James Chih-Hsin Yang
MD, PhD
Director, Graduate Institute of Oncology
👥Biography 个人简介
James Chih-Hsin Yang is one of the most influential lung cancer researchers in Asia who has led multiple landmark EGFR TKI trials including afatinib and osimertinib studies. His work on EGFR exon 20 insertions and uncommon mutations has expanded understanding of EGFR-driven lung cancer heterogeneity. He continues to drive adjuvant and perioperative EGFR-targeted therapy research.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 James Chih-Hsin Yang 的研究动态
Follow James Chih-Hsin Yang's research updates
留下邮箱，当我们发布与 James Chih-Hsin Yang（National Taiwan University）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment